043100 — Alphanox Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for Alphanox Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS/A	ARS/A	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	22,854	23,951	23,396	26,878	26,809
Cost of Revenue
Gross Profit	10,186	8,174	7,648	4,986	8,181
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	22,958	30,253	29,839	47,004	35,554
Operating Profit	-104	-6,302	-6,443	-20,126	-8,745
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,637	-4,179	-8,765	-21,598	-7,496
Provision for Income Taxes
Net Income After Taxes	1,637	-4,179	-8,765	-21,598	-7,496
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,647	-4,075	-8,383	-20,166	-7,080
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,647	-4,075	-8,383	-20,166	-7,080
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	280	-635	-904	-1,493	-748
Dividends per Share